{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T16:20:17Z","timestamp":1785514817999,"version":"3.56.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.jfo.2015.09.011","type":"journal-article","created":{"date-parts":[[2016,1,29]],"date-time":"2016-01-29T01:02:40Z","timestamp":1454029360000},"page":"156-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Long-term tolerance of preservative-free eye drops containing macrogol hydroxystearate as an excipient"],"prefix":"10.1016","volume":"39","author":[{"given":"K.","family":"Viaud-Quentric","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Lefranc-Jullien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Feraille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.-P.","family":"Elena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfo.2015.09.011_bib0135","series-title":"Guidance for industry: nonclinical studies for the safety evaluation of pharmaceutical excipients","author":"Food and Drug Administration","year":"2005"},{"key":"10.1016\/j.jfo.2015.09.011_bib0140","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1136\/bjophthalmol-2012-303040","article-title":"Bimatoprost 0.03% preservative-free ophthalmic solution versus bimatoprost 0.03% ophthalmic solution (Lumigan) for glaucoma or ocular hypertension: a 12-week, randomised, double-masked trial","volume":"97","author":"Day","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2015.09.011_bib0145","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1755-3768.2010.01907.x","article-title":"Switching from a preserved to a preservative-free prostaglandin preparation in topical glaucoma medication","volume":"88","author":"Uusitalo","year":"2010","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.jfo.2015.09.011_bib0150","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.preteyeres.2010.03.001","article-title":"Preservatives in eyedrops: the good, the bad and the ugly","volume":"29","author":"Baudouin","year":"2010","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.jfo.2015.09.011_bib0155","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1136\/bjo.86.4.418","article-title":"Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication","volume":"86","author":"Pisella","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2015.09.011_bib0160","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1097\/ICO.0b013e3181dc81b6","article-title":"Influence of alkyl chain length of benzalkonium chloride on acute corneal epithelial toxicity","volume":"29","author":"Uematsu","year":"2010","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2015.09.011_bib0165","first-page":"175","article-title":"Excipients of preservative-free latanoprost induced inflammatory response and cytotoxicity in immortalized human HCE-2 corneal epithelial cells","volume":"2","author":"Smedowski","year":"2014","journal-title":"J Biochem Pharmacol Res"},{"key":"10.1016\/j.jfo.2015.09.011_bib0170","series-title":"The Association for Research in Vision and Ophthalmology","article-title":"The impact of glaucoma medication on the corneal irritability and effect on corneal healing in case of abrasions","author":"Pinheiro","year":"2014"},{"key":"10.1016\/j.jfo.2015.09.011_bib0175","series-title":"The Association for Research in Vision and Ophthalmology","article-title":"Switch from BAK-preserved to preservative-free latanoprost decreases anterior chamber flare in POAG patients","author":"Kestelyn","year":"2014"},{"key":"10.1016\/j.jfo.2015.09.011_bib0180","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s40261-014-0203-4","article-title":"Preservative-free latanoprost eye drops in patients with primary open-angle glaucoma\/ocular hypertension","volume":"34","author":"Sanford","year":"2014","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.jfo.2015.09.011_bib0185","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1258\/002367796780739871","article-title":"Recommendations for euthanasia of experimental animals: Part 1. DGXI of the European Commission","volume":"30","author":"Close","year":"1996","journal-title":"Lab Anim"},{"key":"10.1016\/j.jfo.2015.09.011_bib0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1258\/002367797780600297","article-title":"Recommendations for euthanasia of experimental animals: Part 2. DGXT of the European Commission","volume":"31","author":"Close","year":"1997","journal-title":"Lab Anim"},{"key":"10.1016\/j.jfo.2015.09.011_bib0195","year":"1992"},{"key":"10.1016\/j.jfo.2015.09.011_bib0200","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0022-3565(25)08751-8","article-title":"Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes","volume":"82","author":"Draize","year":"1944","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jfo.2015.09.011_bib0205","first-page":"181","article-title":"Slit-lamp examination of experimental eyes. II. Grading scales and photographic evaluation of induced pathological conditions","volume":"24","author":"Baldwin","year":"1973","journal-title":"J Soc Cosmet Chem"},{"key":"10.1016\/j.jfo.2015.09.011_bib0210","unstructured":"McDonald TO, Shadduck JA. Eye irritation. In: Marzulli FN, Maibach HI, editors. Dermato toxicology and pharmcology. John Wiley & Sons, New York. Adv Modern Toxicol 1977;4:139\u201391."},{"key":"10.1016\/j.jfo.2015.09.011_bib0215","series-title":"Note for guidance on non-clinical local tolerance testing of medicinal products (CPMP\/SWP\/2145\/00)","author":"European Agency for the Evaluation of Medicinal Products","year":"2001"},{"key":"10.1016\/j.jfo.2015.09.011_bib0220","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1089\/jop.1997.13.369","article-title":"Retinal safety of oral and topical ofloxacin in rabbits","volume":"13","author":"Cohen","year":"1997","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.jfo.2015.09.011_bib0225","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000055579","article-title":"Comparison of the effects of preserved and unpreserved formulations of timolol on the ocular surface of albino rabbits","volume":"32","author":"Pisella","year":"2000","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.jfo.2015.09.011_bib0230","first-page":"359","article-title":"Use of a specular microscope with pachymeter in ocular tolerance studies of eye drops in the rabbit. Evaluation of ocular tolerance of benzalkonium chloride in aqueous solution 0.01% and 0.1%","volume":"7","author":"Santoul","year":"1990","journal-title":"Lens Eye Toxic Res"},{"key":"10.1016\/j.jfo.2015.09.011_bib0235","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0014-4835(72)90137-6","article-title":"Normal corneal staining with fluorescein","volume":"14","author":"Kikkawa","year":"1972","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jfo.2015.09.011_bib0240","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S1094-9194(01)00003-2","article-title":"Corneal diseases of rabbits","volume":"5","author":"Andrew","year":"2002","journal-title":"Vet Clin North Am Exot Anim Pract"},{"key":"10.1016\/j.jfo.2015.09.011_bib0245","first-page":"436","article-title":"Incidence of spontaneous ocular lesions in laboratory rabbits","volume":"61","author":"Holve","year":"2011","journal-title":"Comp Med"},{"key":"10.1016\/j.jfo.2015.09.011_bib0250","series-title":"Clinical pathology of laboratory animals. Animal model in toxicology","author":"Hall","year":"2006"},{"key":"10.1016\/j.jfo.2015.09.011_bib0255","doi-asserted-by":"crossref","first-page":"8172","DOI":"10.1167\/iovs.12-10766","article-title":"In vitro and in vivo comparative toxicological study of a new preservative-free latanoprost formulation","volume":"53","author":"Pauly","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2015.09.011_bib0260","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/bjophthalmol-2012-302121","article-title":"Efficacy and safety of preservative-free latanoprost eyedrops, compared with BAK-preserved latanoprost in patients with ocular hypertension or glaucoma","volume":"97","author":"Rouland","year":"2013","journal-title":"Br J Ophthalmol"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551215004593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551215004593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:05:45Z","timestamp":1759259145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0181551215004593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0181551215004593"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2015.09.011","relation":{},"ISSN":["0181-5512"],"issn-type":[{"value":"0181-5512","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term tolerance of preservative-free eye drops containing macrogol hydroxystearate as an excipient","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2015.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}